Form 8-K · Current Report · Filed 2024-05-07
Kenvue Initiates Restructuring and Reports Q1 2024 Results
Kenvue Inc. announced a multi-year restructuring initiative to optimize its cost structure, aiming for a net global workforce reduction of approximately 4% and annualized pre-tax gross cost savings of $350 million starting in fiscal year 2026. This initiative is expected to result in restructuring expenses and other charges totaling approximately $550 million across fiscal years 2024 and 2025. Additionally, the company released its financial results for the fiscal first quarter ended March 31, 2024.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001944048-24-000096
- CIK
- 0001944048
- Signal
- Medium impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Costs Associated with Exit or Disposal Activities
Financial Statements and Exhibits
Market reaction
Close before filing
$19.08
Next session
+7.2%
Since filing
+0.8%
Latest close
$19.24
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
Exhibits (1)
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.